Asia-Pacific Smart Pills Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Sep 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific Smart Pills Market, By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Stomach, Large Intestine), Disease Indication (Esophageal Diseases, Small Bowl Diseases, Colon Diseases, Others), End Users (Hospitals, Diagnostic Center, Research Institute), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific) Industry Trends and Forecast to 2027

Asia-Pacific Smart Pills Market

Market Analysis and Insights: Asia-Pacific Smart Pills Market

Asia-Pacific smart pills market is expected to gain market grow that a potential rate of 18.67% in the forecast period of 2020 to 2027.

Smart pills can be defined as capsule sized medical device which includes sensors, cameras, patches and trackers that aid efficient diagnostic, targeted drug delivery, and patient monitoring. It helps to analyse health condition of patient once patient swallow the pill which helps in taking effective decision for prescribing medications. In addition smart pills have got revolutionized in the field of gastrointestinal diagnosis.

Rising geriatric population and increasing prevalence of chronic diseases such as diabetes, cancer, obesity, gastroesophageal reflux diseases, gastric ulcers and others are major factor driving market growth whereas rising demand for minimal invasive treatment with early detection of medical problems, technological advancement and innovation of new products such as bioelectronics, micro-cameras, miniatururizartion and others will boost market growth. In addition increasing R&D projects for development of effective smart pills will create lucrative opportunities for market in coming years. However strict regulatory policies and high cost of devices are restraining factors for market whereas side effects of treatment are challenging factors for market.

This Asia-Pacific smart pills market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Smart Pills Market Scope and Market Size

Asia-Pacific smart pills market is segmented on the basis of application, target area, disease indication, and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • Based on application, Asia-Pacific smart pills market is segmented into capsule endoscopy, drug delivery, and patient monitoring.
  • Based on target area, Asia-Pacific smart pills market is segmented into esophagus, small intestine, large intestine, and stomach.
  • Based on disease indication, Asia-Pacific smart pills market is segmented into esophageal diseases, small bowel diseases, colon diseases, and others.
  • Asia-Pacific smart pills market is also segmented on the basis of end user is segmented into hospitals, diagnostic centers, and research institute.

Asia-Pacific Smart Pills Market Country Level Analysis

Asia-Pacific smart pills market is analysed and market size information is provided by country, application, target area, disease indication and end users as referenced above.

The countries covered in the Asia-Pacific smart pills market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC).

China, India and Japan are anticipated to register significant market growth rate during forecast period owing to high pace in technological development and increasing government initiative to improve healthcare infrastructure whereas rising of geriatric population and increasing prevalence of chronic diseases due to changing lifestyle will boost region market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Asia-Pacific smart pills market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Asia-Pacific Smart Pills Market Share Analysis

Asia-Pacific smart pills market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to bone anchored hearing systems market.

The major players covered in the Asia-Pacific smart pills market report are Boston Scientific Corporation, GENERAL ELECTRIC COMPANY, Medtronic, Microchip Technology Inc., Novartis AG, Olympus Medical Technology, Koninklike Philips N.V., Stryker, Pixie Scientific, LLC, Proteus Digital Health, FUJIFILM Holding Corporation, INTROMEDIC, MEDISAFE, Check-Cap, PENTAX Medical, JINSHAN Science & Technology, CapsoVision, HQ Inc., Medimetriks Pharmaceuticals Inc., BDD Pharma, Lucid group Communication Ltd, Otsuka Holdings Co. Ltd. Cerner Corporation, and Vitality, among other domestic and global players. Bone anchored hearing systems market share data is available for global, North America, South America,Europe, Asia-Pacific (APAC) andMiddle East and Africa (MEA)separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Asia-Pacific Smart Pills Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES ASIA-PACIFIC SMART PILLS MARKET

TABLE 1 DIFFERENT CURRENT PROCEDURAL TERMINOLOGY (CPT) CODES FOR CAPSULE ENDOSCOPY PROCEDURES

TABLE 2 PRICES FOR THE CAPSULE ENDOSCOPY

TABLE 3 ASIA-PACIFIC SMART PILLS MARKET, BY APPLICATION, 2016-2025, (USD MILLION)

TABLE 4 ASIA-PACIFIC CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 5 ASIA-PACIFIC CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 6 ASIA-PACIFIC DRUG DELIVERY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 7 ASIA-PACIFIC PATIENT MONITORING OF CANCER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 8 ASIA-PACIFIC SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025, (USD MILLION)

TABLE 9 ASIA-PACIFIC OCCULT GI BLEEDING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 10 ASIA-PACIFIC CROHN’S DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 11 ASIA-PACIFIC SMALL BOWEL TUMORS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 12 ASIA-PACIFIC CELIAC DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 13 ASIA-PACIFIC INHERITED POLYPOSIS SYNDROMES IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 14 ASIA-PACIFIC MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 15 ASIA-PACIFIC MENTAL DISORDERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 16 ASIA-PACIFIC SMART PILLS MARKET, BY TYPE, 2016-2025, (USD MILLION)

TABLE 17 ASIA-PACIFIC MULTIPARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 18 ASIA-PACIFIC SINGLE PARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 19 ASIA-PACIFIC SMART PILLS MARKET, BY END USER, 2016-2025, (USD MILLION)

TABLE 20 ASIA-PACIFIC HOSPITAL IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 21 ASIA-PACIFIC DIAGNOSTIC CENTERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 22 ASIA-PACIFIC OTHERS END USER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 23 ASIA PACIFIC SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)

TABLE 24 ASIA PACIFIC SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 25 ASIA PACIFIC CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 26 ASIA PACIFIC SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 27 ASIA PACIFIC MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 28 ASIA PACIFIC SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 29 ASIA PACIFIC SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 30 CHINA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 31 CHINA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 32 CHINA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 33 CHINA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 34 CHINA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 35 CHINA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 36 JAPAN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 37 JAPAN CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 38 JAPAN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 39 JAPAN MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 40 JAPAN SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 41 JAPAN SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 42 INDIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 43 INDIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 44 INDIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 45 INDIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 46 INDIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 47 INDIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 48 SOUTH KOREA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 49 SOUTH KOREA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 50 SOUTH KOREA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 51 SOUTH KOREA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 52 SOUTH KOREA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 53 SOUTH KOREA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 54 AUSTRALIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 55 AUSTRALIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 56 AUSTRALIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 57 AUSTRALIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 58 AUSTRALIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 59 AUSTRALIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 60 SINGAPORE SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 61 SINGAPORE CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 62 SINGAPORE SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 63 SINGAPORE MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 64 SINGAPORE SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 65 SINGAPORE SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 66 THAILAND SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 67 THAILAND CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 68 THAILAND SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 69 THAILAND MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 70 THAILAND SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 71 THAILAND SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 72 MALAYSIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 73 MALAYSIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 74 MALAYSIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 75 MALAYSIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 76 MALAYSIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 77 MALAYSIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 78 INDONESIA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 79 INDONESIA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 80 INDONESIA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 81 INDONESIA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 82 INDONESIA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 83 INDONESIA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 84 PHILIPPINES SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 85 PHILIPPINES CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 86 PHILIPPINES SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 87 PHILIPPINES MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 88 PHILIPPINES SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 89 PHILIPPINES SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 90 REST OF MIDDLE EAST & AFRICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19